G6 Clinical activity observed in a phase I dose escalation trial of an oral c-met and ALK inhibitor, PF-02341066 (original) (raw)

Adjuvant simultaneous integrated boost IMRT for patients with intermediate- and high-risk head and neck cancer: Outcome, toxicities and patterns of failure

Jan-Dirk Raguse

Oral Oncology, 2014

View PDFchevron_right

Final results of the EORTC 18871/DKG 80-1 randomised phase III trial

Eva-Bettina Brocker

European Journal of Cancer, 2004

View PDFchevron_right

The Treatment Outcome and Radiation-Induced Toxicity for Patients with Head and Neck Carcinoma in the IMRT Era: A Systematic Review with Dosimetric and Clinical Parameters

Stella Thalassinou, John Kouvaris, Christos Antypas

BioMed Research International, 2013

View PDFchevron_right

Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience

Dirk Van Gestel, Dirk Schrijvers

British Journal of Radiology, 2011

View PDFchevron_right

Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225

Mona Sabra

2009

View PDFchevron_right

Intensity Modulated Radiotherapy (IMRT) in the Management of Locally Advanced Oropharyngeal Squamous Cell Carcinomata (SCC): Disease Control and Functional Outcome using the Therapy Outcome Measure (TOM) Score. A Report from a Single UK Institution

Kent Yip

Head & Neck Oncology, 2010

View PDFchevron_right

A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer

Catharine Clark

Radiotherapy and Oncology, 2007

View PDFchevron_right

Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: Preliminary correlations with local control and overall survival

J.-p. Pignon

International Journal of Radiation Oncology*Biology*Physics, 1993

View PDFchevron_right

Challenges in the re-irradiation of locally advanced head and neck cancers: outcomes and toxicities

Naomi Schechter

Journal of Radiation Oncology, 2019

View PDFchevron_right

Comparison of Radiation-Induced Secondary Malignancy Risk Between Sequential and Simultaneous Integrated Boost for the Treatment of Nasopharyngeal Carcinoma: Intensity-Modulated Radiotherapy versus Volumetric-Modulated Arc Therapy

Adnan Yoney

Cancer Management and Research, 2020

View PDFchevron_right

Simultaneous integrated boost-intensity-modulated radiotherapy in head and neck cancer

Marta Casati

2013

View PDFchevron_right

Postoperative IMRT in head and neck cancer

Gabriela Studer

2006

View PDFchevron_right

Clinical outcomes and Toxicity profile with IMRT or Brachytherapy boost in oropharyngeal malignancies: A Randomized, open label study

PRATIBHA BAUSKAR

International Journal of Radiation Oncology*Biology*Physics, 2020

View PDFchevron_right

Head and neck cancer: improving outcomes with a multidisciplinary approach

Marco Merlano

Cancer Management and Research

View PDFchevron_right

Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy

Pramod Sharma

Annals of Oncology, 2012

View PDFchevron_right

Whole-Field Sequential Intensity–Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma

Bharat Mittal

American Journal of Clinical Oncology, 2015

View PDFchevron_right

Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer

Hanna Mortensen, Lena Specht

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2012

View PDFchevron_right

When is definitive radiotherapy the preferred treatment for head and neck squamous cell carcinoma?

Avraham Eisbruch

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2015

View PDFchevron_right

Toxicity, Swallow Function, and Quality of life on MC1273, a Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in HPV+ Oropharynx Squamous Cell Carcinoma

Robert Foote

International Journal of Radiation Oncology Biology Physics, 2018

View PDFchevron_right

Are We Influencing Outcome in Oropharynx Cancer With Intensity-Modulated Radiotherapy? An Inter-Era Comparison

Karen Chura

International Journal of Radiation Oncology Biology Physics, 2007

View PDFchevron_right

Head and neck cancer emerging strategies: advances and new challenges

Gilberto Castro

Current Opinion in Oncology, 2009

View PDFchevron_right

Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience

Ricky Kong

International Journal of Radiation Oncology Biology Physics, 2004

View PDFchevron_right

A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study

Nigel Spry

Radiotherapy and Oncology, 2001

View PDFchevron_right

A randomized prospective study comparing acute toxicity, compliance and objective response rate between simultaneous integrated boost and sequential intensity-modulated radiotherapy for locally advanced head and neck cancer

Lalit Mohan Sharma

Radiation Oncology Journal

View PDFchevron_right

Acute and late normal tissue reactions in the DAHANCA 6&7 randomized trial with accelerated radiotherapy for head and neck cancer

Lena Specht

International Journal of Radiation Oncology*Biology*Physics, 2003

View PDFchevron_right

IMRT in oral cavity cancer

Gabriela Studer

Radiation Oncology, 2007

View PDFchevron_right

Radiobiological evaluation of intensity modulated radiation therapy treatments of patients with head and neck cancer: A dual-institutional study

Ganesh Narayanasamy

Journal of Medical Physics, 2015

View PDFchevron_right

A Systematic Overview of Radiation Therapy Effects in Head and Neck Cancer

Eva Cavallin-ståhl

Acta Oncologica, 2003

View PDFchevron_right